-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
All investors
114 institutional investors
Content Filter
-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
-
GTJA Investment Group
- Investments: 134
- Funds: 87
- Shenzhen, Guangdong Province
-
Lithium batteries
-
Electric vehicles
-
Bio-Tech
Founded in Shenzhen in 2001, GTJA Investment Group focuses on investment in the medical health industry and is dominated by strategic equity investment, covering all stages of mergers and acquisitions, PE, VC, and angels. We have a medical investment team with leading scale and professionalism in China to build a ecoplatform for medical health industry. We are committed to becoming a medical health investment institution with global influence. GTJA's investment layout includes biopharmaceuticals, medical devices and medical services. With an asset management scale of over 20 billion RMB and 35 medical health industry funds, we have invested in more than 160 companies, including more than 90 medical health companies, and promoted the successful listing of 34 companies.
-
Haier Capital
- Investments: 139
- Funds: 19
- Shanghai
-
Lithium batteries
-
Grid/power transmission
-
Other renewable energy (nuclear, geothermal, etc.)
Haier Capital, founded in 2010, is the investment platform of Haier Financial Holding. Our business mainly involve venture capital, private equity investment, industrial mergers and acquisitions, and government guidance funds. Haier Capital focuses on the medical health field, including medical technology, medical services, medical equipments, and biomedicine. So far, we have managed more than 20 billion investment assets. We invest in smart technology, innovative consumption, andmedical health. The investment enterprises include Ijiami, Ubox, Dayun Motor, Dekun, Huatu Education, and Create LED.
-
Hankang Capital
- Investments: 75
- Funds: 13
- Shanghai
-
Photovoltaic
-
Grid/power transmission
-
Digital technology for carbon accounting and consulting
Hankang Capital (formerly "Shanghai Jianxin Capital") is a venture capital focusing on the biomedical industry. We pay attention to major diseases and major clinical needs, carry out in-depth research, support pioneering companies with first-class team and technology platform in advance, and provide professional insights, experience and resources in product pipeline, team building, application and registration, clinical trials, etc. to promote them to become leading enterprises in the industry as soon as possible. We have invested in Innocare Pharma Limited, Akeso, Chip Screen, Keymed Biosciences, AbbiskoTherapeutics and other industry leading companies. Hankang Capital has won the honors such as "TOP 100 Venture Capital Institutions", "TOP 20 Healthcare Investment Institutions", and "TOP 50 Venture Capital Institutions Recognized by LP in China" for many times.
-
Vinno Capital
- Investments: 59
- Funds: 9
- Shenzhen, Guangdong Province
-
Lithium batteries
-
Circular economy
Vinno Capital, initiated by an investment management team with a global vision and experienced industry background, is an early stage venture capital institution focusing on ICT and medical device-related fields. Vinno Capital will search for cutting-edge technologies in China, North America, and Israel, and mainly invest in technologicial innovation enterprises. With rich industrial experience and successful entrepreneurial experience, we have invested in more than 90 outstanding enterprises with innovative genes, and incubated a number of leading enterprises in various industry segments. Our major investment fields include information technology such as artificial intelligence, communication technology, automotive electronics and medical health, such as in vitro diagnosis, imaging diagnosis, precision medicine, mobile medicine, etc.
-
Tsinghua Holding Capital
- Investments: 80
- Funds: 18
- Beijing
-
Energy storage
-
Hydrogen energy
-
Lithium batteries
-
Digital technology for carbon accounting and consulting
Established in 2007, Tsinghua Holdings Capital has a series of VC, PE, industrial funds, M&A funds, overseas funds, and more than 20 sub-funds including general aviation, military industry investment funds invested in different stages and different professional fields, with a management scale of over 10 billion yuan. It is committed to becoming the best private equity investment institution in China and focusing on investing in leading enterprises in sub-sectors, with an emphasis on industries in high-speed development such as advanced manufacturing and high-end equipment, new generation information technology, carbon neutrality and biotechnology. Tsinghua Holdings Capital insists on investment with industrial thinking, selects high-growth enterprises to invest in through in-depth and solid industry research (TOP-DOWN mode), and reduces risks through strict risk control systems. Invested enterprises include Guanglian Aviation, Consys, Triangle, Future Aerospace, Top Alliance, Ronbay Technology, etc.